Donate
Facebook-f X-twitter Linkedin-in

Meeting Information

Official Venue & Headquarter Hotel

The official meeting venue and headquarter hotel is the New Orleans Marriott. All events occur at the hotel, making it the preferred lodging choice. INS has reserved a block of rooms at a special rate exclusively for INS meeting attendees.

The hotel is centrally located in the heart of the city’s famed French Quarter, and is within walking distance of premier attractions such as Jackson Square and the world-famous Bourbon Street. Louis Armstrong New Orleans International Airport, the arrival point for most attendees, is located 13 miles from the hotel.

Hotel booking information will be available when registration opens, typically in October.

Program Information

Welcome to INS New Orleans 2025!

Jessica Fish, PhD

Program Co-Chair

Vonetta Dotson, PhD

Program Co-Chair

INS 2025: Translational Science for Brain Health Equity

We are thrilled to return to New Orleans for the first time since 2017! This wonderfully diverse and resilient city provides an ideal setting for our conference themes. We look forward to an inspiring scientific program and hope you will join us to experience the rich array of offerings in food, culture, and the arts that make New Orleans such a unique city!

Please bookmark this page for additional meeting highlights over the upcoming months!

Message from Vonetta Dotson & Jessica Fish, 2025 INS Program Committee Co-Chairs:

Over the past decade, public interest in brain health has surged. Concurrently, neuropsychology research and practice have broadened their scope to not only address brain-based disorders and understand healthy cognitive functioning, but also promote brain health. This involves optimizing brain functioning across cognitive, emotional, behavioral, and motor domains in both healthy and clinical populations. This broader perspective redefines the role of neuropsychologists, emphasizing prevention, quality of life, and overall well-being, thus enhancing our impact worldwide.

Neuropsychology has a responsibility to ensure that this impact is felt equitably across all individuals and communities. It has long been recognized that social determinants affect brain health, with some communities facing higher risks for negative brain health outcomes and greater obstacles to quality healthcare and behaviors that support brain health. Now, it is imperative to move beyond merely acknowledging these inequities and actively work to reduce them. Central to this effort is conducting translational research that directly benefits brain health and promotes brain health equity. These considerations inspired the theme for the 2025 Annual Meeting in New Orleans: Translational Science for Brain Health Equity

We invite abstract submissions aligned with this theme, including those that explore social determinants affecting the risk, assessment, and treatment of neuropsychological conditions; provide insights into interventions and the optimization of brain health; or address the implementation of research into neuropsychological service delivery. We particularly encourage submissions that focus on minoritized and underrepresented groups, such as racially and ethnically minoritized populations, LGBTQ+ individuals, low socioeconomic groups, and rural communities. Acknowledging that brain health is a lifelong process, and that age is a key diversity consideration, we welcome submissions that incorporate a lifespan perspective and those addressing the intersectionality of age with other diversity aspects. As in previous years, we also encourage submissions that offer unique insights into the neuroscience of healthy and disease states, innovations in measurement and assessment, novel applications of technology in our field, and international perspectives and collaborations.

Programming includes keynote speakers and invited symposia on research, practice, and professional development topics including:

  • Brain health equity across different life stages
  • Services for individuals with sensory impairment
  • Resiliency in professional settings
  • Implementation science
  • Funding for translational and health services research
  • Innovative approaches to incorporating technology into neuropsychological assessment

Call for Abstracts

General Info

Abstract submission is now open! Please read ALL submission guidelines and available presentation formats carefully before you submit. Submissions that do not adhere to posted guidelines may not be considered. Download the Call for Abstracts PDF or continue reading below for complete submission details.

CALL FOR ABSTRACTS PDF
Abstract Submission

Opens: June 6, 2024
Deadline: August 15, 2024

  • INS Membership is not required to submit. INS members will receive discounts on meeting registration and CE fees (if annual dues are paid at the time of registration).
  • Accepted abstracts must be presented by the designated presenting author or by their representative. The corresponding author must formally communicate any changes in the presenting author to abstracts@the-ins.org.
  • Presenters and any authors who will attend the meeting must register and pay a registration fee (CE Workshops require a separate registration, and there is an additional fee to receive CE for plenary and invited symposia). All authors are personally responsible for the arrangement and payment of their personal meeting registration, accommodations, travel, and other meeting-related expenses.
  • Presenting authors must indicate their student status for award consideration.
  • In order to submit, authors must agree to the participant code of conduct.
  • Please Note: All abstract notices are ONLY sent via email to the Submitting Author. It is the submitting author’s responsibility to share any important notices with co-authors.
Schedule Considerations
  • By submitting, authors commit to be available to present on the date and time they are assigned. Accepted abstracts may be scheduled at any time during the four-day meeting at the discretion of the Program Chairs.
  • There is no limitation on the number of submissions, but authors are asked to use discretion because submitting multiple abstracts is likely to create scheduling problems.
  • The submission deadline is Wednesday August 14, 2024 at exactly 11:59pm U.S. Eastern Time (-0400 UTC). All abstracts and symposia must be fully submitted by this time in order to be considered. No late submissions will be accepted. Any abstracts that remain in draft status beyond this deadline will not be considered.
  • All submissions must be made online. Submit abstracts at bit.ly/INS-2025-abstracts (including paper, poster, and symposium abstracts). Symposia proposals must be submitted separately, at bit.ly/INS-2025-symposia.
  • Late breaking abstracts will be accepted, beginning in September and due by October 9, 2024. Late breaking submissions will only be considered as posters, which if accepted, will be presented during a designated late breaking poster session on Saturday February 15, 2025. Complete details will be provided at a later date.
  • The body of submitted abstracts may not exceed 500 words. Paper and Poster submissions must be organized under the following four headings: Objective, Participants and Methods, Results, and Conclusions.
  • Submissions will be published exactly as received. Please proofread carefully before submitting. Once the deadline has passed, we may decline to accommodate requests to correct typos or other errors made during submission.
  • Abstracts may be edited after they have been submitted, but ONLY prior to the submission deadline, and only by the submitting author within the submission system. If an abstract is returned to draft for editing purposes, it MUST be fully re-submitted by the submission deadline in order to be considered.
  • Once the submission deadline has passed, only minimal changes to the formal abstract may be accommodated (including author changes or other crucial content changes, but not to correct typos or simple author-entry errors). Author changes AFTER the posted submission deadline must be emailed to abstracts@the-ins.org for approval and processing. INS reserves the right to decline to accommodate corrections.
  • For questions regarding abstract submission, please contact abstracts@the-ins.org.

Authors may submit individual abstracts for Poster or Paper consideration, or a complete Symposium Proposal, which consists of a symposium summary (submitted by the chair) plus 4-5 linked abstracts.

  1. Poster Sessions: Posters are an effective and popular method for communication of scientific information, providing a more intimate forum for informal discussion than is permitted by regular platform presentations. Poster sessions are typically arranged according to submission category at the discretion of the Program Chairs. Poster presenters are expected to stay with their poster for the duration of the session (typically from 60-90 minutes) to discuss their abstract and answer questions.
  2. Paper Sessions: Paper sessions are topical oral sessions, arranged at the discretion of the Program Chairs. Five to six outstanding abstracts are typically selected for each paper session. Each presenter is given approximately 14-18 minutes (depending on the session) for oral presentation and audience discussion. A moderator will introduce speakers, encourage discussion, and keep the session running on time through strict adherence to stated time limits.
    • While nearly 25% of submissions request oral presentation, we can only accommodate approximately 5% of these as papers due to the constraints of our program. The remaining accepted abstracts will be given the opportunity to present a poster.
  3. Symposia Sessions: Symposia are topical platform sessions dealing with specific issues in clinical neuropsychology. Each symposium must be pre-organized by a single chair, and submitted as an integrated session proposal (consisting of a summary/overview and 4-5 participating abstracts). Symposium proposals that do not meet these criteria will not be considered. The symposium chair is SOLELY responsible for ensuring their symposium proposal is complete and submitted as described.
    • A complete symposium proposal consists of an overview Summary—submitted by the symposium Chair—plus 4-5 Participating Symposium Abstracts (which may be submitted by the chair ,or by the chair’s selected symposium participants). Symposium abstracts should be closely linked and integrated. Participating symposium abstracts must be linked to the Summary within the submission system.
    • Symposia are typically allotted between 75-90 minutes. Each session should be divided between the participating abstracts, and also should include time for a review led by the symposium organizer or a discussant (which should correspond to the symposium summary), as well as a dedicated question and answer period. In the case of a symposium that expresses divergent views on a controversial topic, two longer debate-style talks may also be appropriate.
  • All submissions will be peer reviewed by several members of the Program Committee, who are selected according to their expertise in that category. The Program Committee Chairs will make the final decision on all submissions.
  • Abstracts will be rated on scientific merit, relevance, breadth of audience interest, and quality—including compliance with posted guidelines. Authors should proofread submissions and check for proper English usage prior to finalizing their submission(s).
  • Submitting authors must adhere to the following guidelines:
    • All abstracts must consist of original work. Abstracts submitted to other meetings or that have been previously published should not be submitted and will not be considered.
    • All research, results, and conclusions must be final at the time of submission. Abstracts that are promissory in nature will not be considered.
    • Case reports may be submitted, but should clearly describe the uniqueness of the case and how it addresses critical knowledge gaps in the field.
  • Submitting authors will be notified of acceptance decisions by the end of September 2024, and schedule assignments will be sent by the end of October 2024. Abstract notices are sent only to the submitting author.
  • Abstracts that are accepted and presented at the meeting will be published after the meeting in a supplemental issue of the Journal of the International Neuropsychological Society: JINS.

Each abstract must be submitted under one of the categories listed below. Each abstract must also select at least one (or a maximum of up to three) relevant keyword(s).

  • Acquired Brain Injury (TBI, Concussion, Cerebrovascular Injury and Disease – Adult)
  • Acquired Brain Injury (TBI, Concussion, Cerebrovascular Injury and Disease – Child)
  • Addiction / Dependence
  • ADHD / Attentional Functions
  • Aging
  • Anoxia / Hypoxia
  • Assessment / Psychometrics / Methods (Adult)
  • Assessment / Psychometrics / Methods (Child)
  • Autism Spectrum Disorders / Developmental Disorders / Intellectual Disability
  • Behavioral Neurology / Cerebral Lateralization / Callosal Studies
  • Brain Health Equity
  • Brain Health / Positive Neuropsychology
  • Cancer
  • Career Development / Education / Training
  • Cognitive and Affective Neuroscience
  • Connectomics
  • Cross Cultural Neuropsychology / Clinical Cultural Neuroscience
  • Dementia (Alzheimer’s Disease)
  • Dementia (Non-AD)
  • Disorders of Consciousness / Delirium
  • Drug/Toxin-Related Disorders (Non-Addiction)
  • Emotional, Social and Social Cognitive Processes
  • Epilepsy / Seizures
  • Executive Functions / Frontal Lobes
  • Forensic Neuropsychology / Malingering / Noncredible Presentations
  • Genetics / Genetic Disorders
  • Infectious Disease (HIV / COVID / Hepatitis / Viruses)
  • Intervention / Rehabilitation
  • Language and Speech Functions / Aphasia
  • Learning Disabilities / Academic Skills
  • MCI (Mild Cognitive Impairment)
  • Medical / Neurological Disorders / Other (Adult)
  • Medical / Neurological Disorders / Other (Child)
  • Memory Functions/Amnesia
  • Mood and Anxiety Disorders
  • Movement and Movement Disorders
  • Multiple Sclerosis / ALS / Demyelinating Disorders
  • Neurodegenerative Disorders
  • Neuroimaging
  • Neurophysiology / EEG / ERP
  • Neuropsychiatry / Psychopharmacology
  • Neurostimulation / Neuromodulation
  • Other
  • Prenatal / Perinatal Factors / Prematurity
  • Psychiatric Disorders
  • Schizophrenia / Psychosis
  • Service Evaluation / Program Development
  • Sleep and Sleep Disorders
  • Teleneuropsychology
  • Vascular Brain Health (Adult)
  • Vascular Brain Health (Child)

NEW for 2025! The INS Special Interest Groups (SIGs) will be highlighting selected paper and poster abstracts related to their interest areas at NOLA 2025. To be considered, please include the relevant SIG name as a keyword during the submission process (scroll to keywords beginning with “SIG” to see the complete list).

Submit Online Now

Submit an Abstract
Submit
Submit a Symposium
Submit
(+1) 801-487-0475

ATTN: Neurology Admin/INS
175 N. Medical Dr., 5th Floor, Salt Lake City, Utah 84132, USA

8:00am – 4:00pm (Mountain Time, USA) Monday-Friday.

Membership

Meetings

Education

Publications

INS Committees

Science

Global Engagement

Resources

About INS

Membership
Copyright © 2025 | All Rights Reserved.
Facebook-f X-twitter Linkedin-in
Privacy Policy

Home

Contact Member at Large
Contact a Board of Directors Officer